ProfileGDS5822 / ILMN_2846865
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 72% 71% 78% 75% 48% 68% 86% 89% 88% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 15872
GSM1276600PDAC Late Ablation Control 258.871
GSM1276601PDAC Late Ablation Control 3158.878
GSM1276602PDAC Late Ablation 179.575
GSM1276603PDAC Late Ablation 222.148
GSM1276604PDAC Late Ablation 350.668
GSM1303940PDAC Late Ablation_anti-CTLA4 1267.986
GSM1303941PDAC Late Ablation_anti-CTLA4 2534.189
GSM1303942PDAC Late Ablation_anti-CTLA4 3475.888